← Back to context

Comment by caminante

2 days ago

Right? I learned too.

As I mentioned above (another comment), pharma tends to avoid developing applications for generic/cheap drugs so we may not see more research on this front. Who knows.

Big Pharma is more greedy than evil.

If there is a x5 improvement they will get a method to package both drugs together and sell them for x10 the price. You surely want a profesional mix in the high tech lab instead of a random guy mixing tubes in the back room. Another trick is to add something to the molecule like a methyl -CH3, show that the new version is 10% even better and charge x20 for it.

So my guess is that there is some problem to use this mix, but as I said I can't find any obvious error and it's really interesting. I'd love to read a better analysis from someone that is an expert in the area.